Synthesis and biological activity of 8-azapurine and pyrazolo[4,3-d]pyrimidine analogues of myoseverin

被引:40
作者
Krystof, Vladimir
Moravcova, Daniela
Paprskarova, Martina
Barbier, Pascale
Peyrot, Vincent
Hlobilkova, Alice
Havlicek, Libor
Strnad, Miroslav
机构
[1] Palacky Univ, Lab Growth Regulat, Fac Sci, Olomouc 78371, Czech Republic
[2] Inst Expt Bot ASCR, Olomouc 78371, Czech Republic
[3] Isotope Lab, Inst Expt Bot ASCR, Prague 14220 4, Czech Republic
[4] Univ Mediterranee, Fac Pharm, FRE CNRS 2737 ISPDCT, F-13385 Marseille 05, France
[5] Palacky Univ, Fac Med, Lab Mol Pathol, Inst Pathol, Olomouc 77515, Czech Republic
关键词
myoseverin; purine; tubulin; cyclin-dependent kinase; cytoskeleton;
D O I
10.1016/j.ejmech.2006.07.004
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The trisubstituted purine myoseverin has been recently identified as a novel inhibitor of microtubule assembly. To analyze the effects of modifying its heterocyclic skeleton, we prepared 8-azapurine and pyrazolo[4,3-d]pyrimidine analogues of myoseverin and compared their biological activities. Rearrangement of nitrogen atoms in the heterocycle chances the affinity of the compounds to purified tubulin, as demonstrated by the results of polymerization assays, and affects the proliferation of cancer cell lines. Surprisingly, compound E2GG, a pyrazolo[4,3-d]pyrimidine analogue of myoseverin, displayed inhibitory activity towards both tubulin polymerization and the activity of cyclin-dependent kinases 1, 2 and 7. Such a dual specificity-inhibitor offers a starting point for developing a novel class of antiproliferative agents. (c) 2006 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1405 / 1411
页数:7
相关论文
共 23 条
[1]   INTERACTION OF TUBULIN WITH BIFUNCTIONAL COLCHICINE ANALOGS - AN EQUILIBRIUM STUDY [J].
ANDREU, JM ;
GORBUNOFF, MJ ;
LEE, JC ;
TIMASHEFF, SN .
BIOCHEMISTRY, 1984, 23 (08) :1742-1752
[2]  
BARALDI PG, 1991, FARMACO, V46, P1337
[3]   In vitro effect of cryptophycin 52 on microtubule assembly and tubulin: Molecular modeling of the mechanism of action of a new antimitotic drug [J].
Barbier, P ;
Gregoire, C ;
Devred, F ;
Sarrazin, M ;
Peyrot, V .
BIOCHEMISTRY, 2001, 40 (45) :13510-13519
[4]   Synthesis and biological evaluation of myoseverin derivatives: Microtubule assembly inhibitors [J].
Chang, YT ;
Wignall, SM ;
Rosania, GR ;
Gray, NS ;
Hanson, SR ;
Su, AI ;
Merlie, J ;
Moon, HS ;
Sangankar, SB ;
Perez, O ;
Heald, R ;
Schultz, PG .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (26) :4497-4500
[5]   Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor [J].
Davies, TG ;
Bentley, J ;
Arris, CE ;
Boyle, FT ;
Curtin, NJ ;
Endicott, JA ;
Gibson, AE ;
Golding, BT ;
Griffin, RJ ;
Hardcastle, IR ;
Jewsbury, P ;
Johnson, LN ;
Mesguiche, V ;
Newell, DR ;
Noble, MEM ;
Tucker, JA ;
Wang, L ;
Whitfield, HJ .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (10) :745-749
[6]   Tubulyzine®, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success [J].
El Fahime, E ;
Bouchentouf, M ;
Benabdallah, BF ;
Skuk, D ;
Lafreniere, JF ;
Chang, YT ;
Tremblay, JP .
BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2003, 81 (02) :81-90
[7]   Microtubule regulation in mitosis: Tubulin phosphorylation by the cyclin-dependent kinase Cdk1 [J].
Fourest-Lieuvin, A ;
Peris, L ;
Gache, V ;
Garcia-Saez, I ;
Juillan-Binard, C ;
Lantez, V ;
Job, D .
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (03) :1041-1050
[8]   Effect of the purine derivative myoseverin and of its analogues on cultured hybridoma cells [J].
Franek, F ;
Siglerová, V ;
Havlícek, L ;
Strnad, M ;
Eckschlager, T ;
Weigl, E .
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 2002, 67 (02) :257-266
[9]   8-Azapurines as new inhibitors of cyclin-dependent kinases [J].
Havlicek, L ;
Fuksova, K ;
Krystof, V ;
Orsag, M ;
Vojtesek, B ;
Strnad, M .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (18) :5399-5407
[10]   Cytokinin-derived cyclin-dependent kinase inhibitors: Synthesis and cdc2 inhibitory activity of olomoucine and related compounds [J].
Havlicek, L ;
Hanus, J ;
Vesely, J ;
Leclerc, S ;
Meijer, L ;
Shaw, G ;
Strnad, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (04) :408-412